Efficacy of imatinib maintenance after stem cell transplantation for Ph+/BCR::ABL1 positive ALL: long-term outcome of a randomized trial and impact of peritransplant minimal residual disease

Lung, Respiratory and Thoracic Cancer

Disease characteristics and treatment outcomes in patients with resected early-stage ALK-positive non-small cell lung cancer from the randomized ALINA trial

Lung Cancer

Barlesi F, Ahn JS, Solomon BJ, Nishio M, Dziadziuszko R, Lee DH, Lee JS, Zhong W, Horinouchi H, Mao W, Hochmair M, de Marinis F, Migliorino MR, Bondarenko I, Xu T, Bara I, Ding B, Ngiam C, Petric P, Wu YL

doi: 10.1016/j.lungcan.2026.109385

Lymphoma

The long-term efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in the treatment of primary central nervous system lymphoma: A real-world report from the Polish Lymphoma Research Group

Eur J Cancer

Ostrowska B, Domanska-Czyz K, Giza A, Taszner M, Tomaszewska A, Targonski L, Dabrowska-Iwanicka A, Poplawska L, Konecki R, Kotarska M, Szymanski M, Borawska A, Swierkowska M, Druzd-Sitek A, Paszkiewicz-Kozik E, Mroz-Zycinska E, Zimowska-Curyło D, Owczarek-Kaczmarek J, Drozd-Sokolowska J, Tajer J, Osiadacz W, Rymkiewicz G, Michalski W, Basak G, Krzanowski J, Sacha T, Zaucha JM, Walewski J, Romejko-Jarosinska J

doi: 10.1016/j.ejca.2026.116789

Further Publications

Factors associated with long-term quality of life after allogenic stem cell transplantation

Leuk Lymphoma

Domínguez-García JJ, Escamilla MS, García-Ávila S, López Pereira B, Martín Sánchez G, Cortés Vázquez MÁ, Calvo Sánchez JA, Fernández García S, Vega Suárez LP, Ocio San Miguel EM, Bermúdez Rodríguez MA, Yáñez San Segundo L

doi: 10.1080/10428194.2025.2564769

Genitourinary Cancer

Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trial

BJU Int

Sushentsev N, Warren AY, Colling R, Verrill C, Pazukhina E, Blyuss O, Zaikin A, Seibert TM, Barrett T, Oxley J, Mills IG, Bryant RJ, Lane JA, Donovan JL, Neal DE, Hamdy FC

doi: 10.1111/bju.70261

Further Publications

Low-dose ruxolitinib for graft-versus-host disease prevention in haploidentical haematopoietic stem-cell transplantation: a multicentre, open-label, randomised, controlled, phase 3 trial

Lancet Haematol

Wu H, Shi W, Shi Z, Luo Y, Yu J, Cao W, Cao J, Xu X, Hu X, Lu Y, Fu H, Liu L, Lai X, Yang L, Ye Y, Zhang C, Shi J, Huang H, Zhao Y

doi: 10.1016/S2352-3026(26)00167-5

Further Publications

Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trial

Blood

Meyer E, Salhotra A, Gandhi A, Pantin J, Patel SS, Hoeg RT, Gomez-Arteaga A, Faramand RG, Tamari R, Waller EK, Kosuri S, Jimenez Jimenez AM, Holter-Chakrabarty J, Dholaria B, Chen YB, Hamilton BK, Magenau JM, Eghtedar A, Murray JM, Pavlova A, Fernhoff NB, McClellan JS, Killian S, Li A, Negrin RS, Oliai C

doi: 10.1182/blood.2025031313

Leukemia

Outcomes after a second allogeneic haematopoietic stem cell transplant for relapsed paediatric acute myeloid leukaemia improved over time: A study from the EBMT Paediatric Diseases Working Party

Br J Haematol

Buchbinder N, Michel V, Dalissier A, Kleinschmidt K, Locatelli F, Maschan A, Wynn R, Fagioli F, Zecca M, Jubert C, Versluys B, Sedlacek P, Zubarovskaya L, Gonzalez Vicent M, Biffi A, Michel G, Mirci-Danicar O, Holter W, Ansari M, Galimard JE, Schneider P, Abouqateb M, Kałwak K

doi: 10.1111/bjh.70167

Non-Malignant Blood Disorders

RBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report

Am J Hematol

Inam Z, Stenger E, John TD, Liu K, Gillespie S, Shah R, Chellapandian D, Bhatia M, Chaudhury S, Eckrich MJ, Guilcher GMT, Hendrickson JE, Hulbert ML, Jaroscak JJ, Kasow KA, Camacho-Bydume C, Ngwube A, Olson TS, Rangarajan HG, Horan JT, Krishnamurti L, Shenoy S, Abraham A, Nickel RS

doi: 10.1002/ajh.70200

Gastrointestinal Cancer

Comparing short- and long-term survivors in metastatic pancreatic cancer: Insights into patient and disease profiles impacting systemic therapy outcomes

Eur J Cancer

Graus MUJE, van Diepen AE, Broekman T, van Eijck CWF, van Hooft JE, Homs MYV, Wumkes ML, Wilmink JW, de Hingh IHJT, Valkenburg-van Iersel LBJ, van der Geest LGM, Vos-Geelen J, Dutch Pancreatic Cancer Group (DPCG)

doi: 10.1016/j.ejca.2026.116263

Related content

Disease characteristics and treatment outcomes in patients with resected early-stage ALK-positive non-small cell lung cancer from the randomized ALINA trial

The long-term efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in the treatment of primary central nervous system lymphoma: A real-world report from the Polish Lymphoma Research Group

Factors associated with long-term quality of life after allogenic stem cell transplantation

Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trial

Low-dose ruxolitinib for graft-versus-host disease prevention in haploidentical haematopoietic stem-cell transplantation: a multicentre, open-label, randomised, controlled, phase 3 trial

Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trial

Outcomes after a second allogeneic haematopoietic stem cell transplant for relapsed paediatric acute myeloid leukaemia improved over time: A study from the EBMT Paediatric Diseases Working Party

RBC Alloimmunization Impacts Pediatric Sickle Cell Disease Transplant Outcomes and Transfusion Burden: A STAR Registry Report

Comparing short- and long-term survivors in metastatic pancreatic cancer: Insights into patient and disease profiles impacting systemic therapy outcomes